Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRANSCAT INC Director's Dealing 2006

Jul 20, 2006

32421_dirs_2006-07-20_941afedc-391c-4755-a33a-4b687cdc5dff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSCAT INC (TRNS)
CIK: 0000099302
Period of Report: 2006-07-18

Reporting Person: PALMER HARVEY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-07-18 Common Stock, $.50 par value M 4000 $2.00 Acquired 64913 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-07-18 Warrant (Right to Buy) $2.00 M 4000 Disposed 2006-08-21 Common Stock, par value $.50 per share (4000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant (Right to Buy) $.97 2007-08-19 Common Stock, par value $.50 per share (4000) 4000 Direct
Warrant (Right to Buy) $2.31 2008-08-19 Common Stock, par value $.50 per share (4000) 4000 Direct
Warrant (Right to Buy) $2.88 2009-08-17 Common Stock, par value $.50 per share (4000) 4000 Direct
Warrant (Right to Buy) $4.26 2010-08-16 Common Stock, par value $.50 per share (4000) 4000 Direct

Footnotes

F1: Dr. Palmer has elected to defer receipt of 5,466 of these shares, all of which are credited to his participant stock account under the Transcat, Inc. Amended and Restated Directors' Stock Plan, until the expiration of the deferral period, at which time the shares will be issued to him pursuant to the terms of his prior election.

F2: This non-transferable warrant was previously reported by Dr. Palmer.

F3: This non-transferable warrant was previously reported by Dr. Palmer. Dr. Palmer can exercise this warrant in cumulative increments of 1,000 shares after each of the following dates, providing the market price of the Company's Common Stock meets or exceeds, for 20 of 30 consecutive trading days, the following respective amounts: 8/20/02--$2.25; 1/1/03--$3.50; 1/1/04--$5.25; 1/1/05--$7.50; to the extent such market price requirements are not satisfied, the balance of the warrant becomes exercisable on 8/20/06.

F4: This non-transferable warrant was previously reported by Dr. Palmer. Dr. Palmer can exercise this warrant pro rata with respect to one-third of the shares subject to the warrant on the first, second and third anniversaries of the 8/20/03 grant date.

F5: This non-transferable warrant was previously reported by Dr. Palmer. Dr. Palmer can exercise this warrant pro rata with respect to one-third of the shares subject to the warrant on the first, second and third anniversaries of the 8/18/04 grant date.

F6: This non-transferable warrant was previously reported by Dr. Palmer. Dr. Palmer can exercise this warrant pro rata with respect to one-third of the shares subject to the warrant on the first, second and third anniversaries of the 8/17/05 grant date.